Skip to content

Drug interactions

Mycophenolate mofetil + Upadacitinib

Severity: Contraindicated

Mycophenolate mofetil and Upadacitinib: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs suppress the immune system, and together they increase the risk of serious infections and malignancy. Upadacitinib labeling advises against use with potent immunosuppressants.

What this interaction means in plain words

Mycophenolate mofetil and Upadacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Mycophenolate mofetil belongs to Miscellaneous; Upadacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Additive immunosuppression via inhibition of lymphocyte proliferation and JAK signalling.

What to do

Avoid the combination; select an alternative regimen. If unavoidable, monitor closely for infection.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mycophenolate mofetil and Upadacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mycophenolate mofetil with Upadacitinib?

MediHelp rates the interaction as contraindicated. Mycophenolate mofetil and Upadacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Both drugs suppress the immune system, and together they increase the risk of serious infections and malignancy. Upadacitinib labeling advises against use with potent immunosuppressants.

How serious is the interaction between Mycophenolate mofetil and Upadacitinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; select an alternative regimen. If unavoidable, monitor closely for infection.

What other medicines interact with Mycophenolate mofetil?

MediHelp also lists interactions of Mycophenolate mofetil with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Mycophenolate mofetil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in